Lymphangioleiomyomatosis, a Study on Cathepsin K
- Conditions
- Tuberous Sclerosis ComplexLymphangioleiomyomatosis
- Registration Number
- NCT05323370
- Lead Sponsor
- University Hospital, Tours
- Brief Summary
This is a physiopathological case-control, non-interventional, monocentric study of adult patients with lymphangioleiomyomatosis. The controls are patients followed in neurology at the CHU of Tours for a tuberous sclerosis complex without lymphangioleiomyomatosis, the healthy volunteers are women with neither pulmonary nor renal pathology and recruited at the clinical investigation centre of the CHU of Tours.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 19
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method urine cathepsin K proteins levels inclusion visit comparison of urine cathepsin K protein levels in the 3 groups
urine cathepsin K activity inclusion visit comparison of urine cathepsin K activity in the 3 groups
- Secondary Outcome Measures
Name Time Method urinary quantity of cystatin C inclusion visit comparison of urine cystacin C quantity in the 3 groups
FEV1 measurement inclusion visit most recent FEV1 measurement as % of predicted value in lymphangioleiomyomatosis patients
serum level of chondroitin sulphates inclusion visit measurement in lymphangioleiomyomatosis patients
urinary quantity C and N-telopeptides of type 1 collagen inclusion visit comparison in the 3 groups
VEGF-D measurement inclusion visit most recent measurement of VEGF-D blood levels in lymphangioleiomyomatosis patients
T-score measurement inclusion visit T-score measurement of the most recent bone densitometry in lymphangioleiomyomatosis patients
renal angiolipomas inclusion visit measurement of the size of renal angiomyolipomas in lymphangioleiomyomatosis patients
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University hospital
🇫🇷Tours, France
University hospital🇫🇷Tours, France